Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery
- PMID: 25643990
- DOI: 10.1016/j.ejpb.2015.01.018
Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery
Abstract
The unique structure and protective mechanisms of the eye result in low bioavailability of ocular drugs. Using a mucoadhesive material is an efficient solution to improve ocular drug therapeutic efficacy. This study was designed to prepare a liposomal formulation coated by a novel adhesive excipient, silk fibroin (SF), for topical ocular drug delivery. The regenerated silk fibroins (SFs) with different dissolving time were coated onto the ibuprofen-loaded liposomes. The morphology, drug encapsulation efficiency, in vitro release and in vitro corneal permeation of SF-coated liposomes (SLs) were investigated in comparison with the conventional liposome. Cellular adhesion and cytotoxicity assay of SF and SLs were tested using human corneal epithelial cells (HCEC). SLs showed sustained drug release and in vitro corneal permeation of ibuprofen as compared to drug solution and conventional liposome. The cellular fluorescence appeared after 7 min of exposure to SF, and the intensity increased sustainedly up to 12h with no detectable cytotoxicity. Higher fluorescence intensity of Nile red in SLs was observed in a short period of 15 min showing a rapid uptake. These favorable properties make SF-coated liposome be a promising ocular drug delivery system.
Keywords: Cell culture; Coating; Liposomes; Ocular drug delivery; Silk fibroin; Sustained release.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Natural Non-Mulberry Silk Nanoparticles for Potential-Controlled Drug Release.Int J Mol Sci. 2016 Dec 1;17(12):2012. doi: 10.3390/ijms17122012. Int J Mol Sci. 2016. PMID: 27916946 Free PMC article.
-
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.Int J Pharm. 2007 Aug 16;341(1-2):221-9. doi: 10.1016/j.ijpharm.2007.03.043. Epub 2007 Apr 3. Int J Pharm. 2007. PMID: 17499461
-
Ion-induced fabrication of silk fibroin nanoparticles from Chinese oak tasar Antheraea pernyi.Int J Biol Macromol. 2015 Aug;79:316-25. doi: 10.1016/j.ijbiomac.2015.04.052. Epub 2015 Apr 30. Int J Biol Macromol. 2015. PMID: 25936281
-
Recent advances in ocular drug delivery.Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617. doi: 10.3109/03639045.2012.736515. Epub 2012 Nov 16. Drug Dev Ind Pharm. 2013. PMID: 23153114 Review.
-
Silk fibroin as a vehicle for drug delivery applications.J Control Release. 2011 Mar 10;150(2):128-41. doi: 10.1016/j.jconrel.2010.11.007. Epub 2010 Nov 6. J Control Release. 2011. PMID: 21059377 Review.
Cited by
-
Tissue Regeneration: A Silk Road.J Funct Biomater. 2016 Aug 5;7(3):22. doi: 10.3390/jfb7030022. J Funct Biomater. 2016. PMID: 27527229 Free PMC article. Review.
-
Supercritical carbon dioxide-developed silk fibroin nanoplatform for smart colon cancer therapy.Int J Nanomedicine. 2017 Oct 20;12:7751-7761. doi: 10.2147/IJN.S145012. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29118580 Free PMC article.
-
Silk Fibroin-Coated Liposomes as Biomimetic Nanocarrier for Long-Term Release Delivery System in Cancer Therapy.Molecules. 2021 Aug 15;26(16):4936. doi: 10.3390/molecules26164936. Molecules. 2021. PMID: 34443524 Free PMC article.
-
Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review.Pharmaceutics. 2020 Dec 18;12(12):1232. doi: 10.3390/pharmaceutics12121232. Pharmaceutics. 2020. PMID: 33353013 Free PMC article. Review.
-
Advances in Liposomal Interleukin and Liposomal Interleukin Gene Therapy for Cancer: A Comprehensive Review of Preclinical Studies.Pharmaceutics. 2025 Mar 18;17(3):383. doi: 10.3390/pharmaceutics17030383. Pharmaceutics. 2025. PMID: 40143046 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources